AKT1 and cancer: Interestingly, consistent with findings on other cancers, several lines of evidence suggest that CUR exerts its anticancer effects in TC by targeting and suppressing the activation of the PI3K/AKT [31] and STAT3 [30,31,32] signaling pathways.